NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

Description

NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months. Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months. ## Contract award Title: Lot 1 - CM/PHR/25/5730/01 - NHS Branded Medicines Tranche A for Midlands & East Lots: - Lot 1: CM/PHR/25/5730/01 - Tranche B for NOFE and MAE ## Contract award Title: Lot 2 - CM/PHR/25/5730/02 - Natalizumab for London & South of England Lots: - Lot 2: CM/PHR/25/5730/02 - Natalizumab for London & SOFE